Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA
ChemBioChem · 2025
DOI: 10.1002/cbic.202500513 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Halana C Vlaming und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Medical Centre, Dept. Cell and Chemical Biology, Leiden, 2333 ZC, The Netherlands. Hauptthemen laut MEDLINE: Legionella pneumophila, High-Throughput Screening Assays, Bacterial Proteins, ADP Ribose Transferases. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, European Research Council, ERC.
Abstract (Originalsprache)
Ubiquitination of proteins is one of the most crucial post‐translational modifications in eukaryotic cells, typically involving conjugation of ubiquitin to a lysine residue in a substrate using a three‐enzyme cascade that relies on ATP as energy source. The pathogen Legionella pneumophila , in contrast, employs a totally divergent pathway to ubiquitinate cellular host proteins in an unconventional manner that is crucial for bacterial proliferation. This multistep process is orchestrated by effector proteins from the SidE family which initially use NAD + to adenosine diphosphate (ADP)‐ribosylate ubiquitin in a mono‐ADP‐ribosyltransferase (mART) domain. The subsequent step relies on SidE phosphodiesterase activity to conjugate phosphoribosyl‐Ubiquitin to serine residues in host substrates. Through these phosphoribosyl‐ubiquitinating events, Legionella is able to gain local control over the host's ubiquitin system and simultaneously evades immune responses. Hence, pursuing new inhibitors which can disrupt these crucial steps in bacterial infection are essential towards further understanding and potentially blocking Legionella infection. Here, we present the application of an ε ‐NAD + consumption‐based fluorogenic assay to identify small molecule modulators of the SdeA effector enzyme in a High‐Throughput Screening format, where over 600 compounds were screened. As a result, a potent inhibitor named cephalosporin C Zn 2+ salt was discovered showing an IC 50 of 221 nM. To investigate the inhibitory properties more deeply, various cephalosporin analogs were synthesized where variations in charge and carbon length were introduced and their inhibitory efficiencies measured and compared. Our findings suggest that the inhibition is primarily attributed to the presence of the Zn 2+ ion, rather than the cephalosporin core. We next compared the inhibitory potential of other bivalent metal ions, illustrating that the zinc ion causes the best inhibition of the Legionella effector.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leiden University Medical Centre, Dept. Cell and Chemical Biology, Leiden, 2333 ZC, The Netherlands.
ORCID-Profile: Gerbrand J van der Heden van Noort
Förderung
- Dutch Research Council
- European Research Council
- ERC
Zitieren
APA
Vlaming, H. C., Pol, V., van Doodewaerd, B. R., Moutsiopoulou, A., Geurink, P. P., Kim, R. Q., & van der Heden van Noort, G. J. (2025). Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA. ChemBioChem. https://doi.org/10.1002/cbic.202500513
Vancouver
Vlaming HC, Pol V, van Doodewaerd BR, Moutsiopoulou A, Geurink PP, Kim RQ, et al. Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA. ChemBioChem. 2025. doi:10.1002/cbic.202500513
BibTeX
@article{Vlaming2025,
author = {Vlaming, Halana C and Pol, Vito and van Doodewaerd, Bjorn R and Moutsiopoulou, Angeliki and Geurink, Paul P and Kim, Robbert Q and van der Heden van Noort, Gerbrand J},
title = {Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500513}
}
EUVIMED